Pricing

Altimmune Inc (ALT)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Vipin K. Garg
Employees:
50
910 CLOPPER ROAD, SUITE 201S, GAITHERSBURG, MD, 20878
2406541450
    Formally known as:
  • Healthcare Acquisition Corp

Are you looking for this stock instead?

Stock Split History
DateRatio
2018-09-14 1:30
Altimmune, Inc. focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatitis.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available